Section Arrow
SMTI.NASDAQ
- Sanara MedTech
Quotes are at least 15-min delayed:2025/11/15 10:01 EST
Regular Hours
Last
 21.54
+1.93 (+9.84%)
Day High 
22.65 
Prev. Close
19.61 
1-M High
31.66 
Volume 
108.35K 
Bid
21.3
Ask
25.86
Day Low
19.5189 
Open
19.61 
1-M Low
19.1 
Market Cap 
174.58M 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 26.66 
20-SMA 28.25 
50-SMA 30.74 
52-W High 38.75 
52-W Low 19.1 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-1.16/-0.84
Enterprise Value
206.50M
Balance Sheet
Book Value Per Share
3.98
Cash Flow
Cash Flow Yield
0.02
Income Statement
Total Revenue
11.77M
Operating Revenue Per Share
6.70
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
MLSSMilestone Scientific0.33-0.0497-13.09%-- 
AVTRAvantor11.38-0.32-2.74%11.55PE
BAXBaxter International18.47-0.23-1.23%140.32PE
HOLXHologic74.15-0.11-0.15%30.81PE
XRAYDENTSPLY SIRONA10.52-0.43-3.93%-- 
Quotes are at least 15-min delayed:2025/11/15 10:01 EST
Industry overview quotes are at least 15 minutes delayed
Business Description
Sanara MedTech Inc is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the chronic and surgical wound and skincare markets. Its portfolio of products and services allows it to deliver comprehensive wound and skincare solutions for patients in all care settings, including acute and post-acute. Its surgical wound care products are CellerateRX Surgical ActivatedCollagen. Its chronic wound care products are BIAKOS Skin and Wound Cleanser, and BIAKOS Skin and Wound Gel.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.